Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    Alzheimer’s Disease | Open Studies | Exclude Unknown | NCCAM
Show Display Options
Rank Status Study
1 Recruiting A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: NIC5-15;   Drug: Placebo
2 Not yet recruiting Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Meganatural-Az Grapeseed Extract;   Drug: Placebo

Indicates status has not been verified in more than two years